Objective
to investigate the 16-year cardiovascular outcomes in patients with STEMI treated with primary PCI vs fibrinolysis
Study
national, multicentre, randomized controlled enrolling patients at both invasive and referral centres between December 1997 to October 2001
Population
age â¥18 with STEMI (â¥30 mins â¤12 hours from pain onset) (and estimated transfer time â¤3 hours to cath lab if applicable)
Endpoints
composite of death or rehospitalisation for myocardial infarction (MI)
Conclusion
in patients with STEMI the benefit of primary PCI (with or without interhospital transfer) over fibrinolysis was maintained at 16-year follow-up
Thrane et al. Eur Heart J. 2019;0:1-8
